Despite an extensive research directed at characterizing the cytoskeletal protein defects associated with aging and age-related neurodegeneration, the nature of the modifications responsible for protein deposition, insolubility, and proteolytic resistance remain elusive. Of particular relevance are neurofibrillary tangles in Alzheimer's disease, spheroids in amyotrophic lateral sclerosis, and Lewy bodies in Parkinson's disease. Although one or more factors appear to induce a transition between monomeric and non-covalent-associated forms of the constituent proteins, mainly neurofilaments (NF) or tau, the applicant postulates, and has preliminary evidence, that oxidative stress processes lead to an irreversible """"""""cementing"""""""" of protein aggregates, at least in part, through covalent crosslinking. Modification involves a combination of direct oxidation of protein side chains and adduction of products of glycoxidation and lipid peroxidation that is expected to be manifested in overlapping but distinct patterns of markers for the three disease states. Thus, knowledge of individual disease variations in the structure and extent of these markers is hypothesized to help clarify the mechanisms of disease pathogenesis and provide clues for designing ameliorative agents/approaches. The proposal represents a multidisciplinary collaboration among three mid-career investigators with expertise in organic/peptide chemistry (Sayre), protein/analytical biochemistry (Anderson), and neuropathology/immunobiochemistry (Perry), with the goal of defining the structural basis of irreversible protein deposition.
The aims are (i) structural elucidation of the crosslink and non-crosslink-carbonyl oxidative modifications in the protein deposits using novel mass-spectral biochemical analyses, (ii) development of antibodies to oxidation-specific NF and tau conformational epitopes and to structurally defined oxidative lesions, and (iii) correlative evaluation of spatio-temporal distribution of the oxidative-specific markers across different brain regions and their pathobiological significance.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG014249-01A1
Application #
2396694
Study Section
Physiological Chemistry Study Section (PC)
Program Officer
Oliver, Eugene J
Project Start
1997-08-15
Project End
2000-07-31
Budget Start
1997-08-15
Budget End
1998-07-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Zhu, Xiongwei; Castellani, Rudy J; Moreira, Paula I et al. (2012) Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. Free Radic Biol Med 52:699-704
Tang, Xiaoxia; Sayre, Lawrence M; Tochtrop, Gregory P (2011) A mass spectrometric analysis of 4-hydroxy-2-(E)-nonenal modification of cytochrome c. J Mass Spectrom 46:290-7
Zhu, Xiaochun; Sayre, Lawrence M (2007) Long-lived 4-oxo-2-enal-derived apparent lysine michael adducts are actually the isomeric 4-ketoamides. Chem Res Toxicol 20:165-70
Yuan, Quan; Zhu, Xiaochun; Sayre, Lawrence M (2007) Chemical nature of stochastic generation of protein-based carbonyls: metal-catalyzed oxidation versus modification by products of lipid oxidation. Chem Res Toxicol 20:129-39
Zhu, Xiaochun; Sayre, Lawrence M (2007) Mass spectrometric evidence for long-lived protein adducts of 4-oxo-2-nonenal. Redox Rep 12:45-9
Puttaiah, Shivaprakash; Zhang, Yuming; Pilch, Heather A et al. (2006) Detection of dideoxyosone intermediates of glycation using a monoclonal antibody: characterization of major epitope structures. Arch Biochem Biophys 446:186-96
Sayre, Lawrence M; Lin, De; Yuan, Quan et al. (2006) Protein adducts generated from products of lipid oxidation: focus on HNE and one. Drug Metab Rev 38:651-75
Lin, De; Lee, Hyoung-gon; Liu, Quan et al. (2005) 4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal. Chem Res Toxicol 18:1219-31
Sun, Gang; Anderson, Vernon E (2005) A strategy for distinguishing modified peptides based on post-digestion 18O labeling and mass spectrometry. Rapid Commun Mass Spectrom 19:2849-56
Mandal, Subrata; Kazmi, Najam H; Sayre, Lawrence M (2005) Ligand dependence in the copper-catalyzed oxidation of hydroquinones. Arch Biochem Biophys 435:21-31

Showing the most recent 10 out of 49 publications